OmniComm's TrialMasterTM EDC Solution Selected By Leading Medical Device Manufacturer For Phase IV Cardiovascular Device Study

Main Category: Medical Devices / Diagnostics
Also Included In: Cardiovascular / Cardiology;  Heart Disease
Article Date: 18 Nov 2009 - 10:00 PDT

email to a friend   printer friendly   opinions  

OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace, announced today that a leader in the medical device industry has selected OmniComm's TrialMaster EDC solution for the data capture of a Phase IV cardiovascular study. The 24-month, 7-site study will enroll 100 subjects.

"We look forward to continuing our successful collaboration with this device company," remarked Stephen Johnson, COO of OmniComm Systems. "Our flagship EDC solution, TrialMaster, has already proven to be an efficient and reliable data capture system for 12 of this customer's studies during the past 5 years. This is proof positive that the high quality of our EDC solutions and our outstanding customer service continue to generate the high percentage of return business needed to sustain our current rate of growth."

Source
OmniComm

• Additional
• References
• Citations